This insurance plan has been introduced in response to the rapidly growing
rate of cancer diagnosis worldwide and the booming cost of cancer care and treatments.
With a rapidly growing
rate of cancer diagnosis in the world, there are several reasons why you might want to invest in this type of a policy.
Not exact matches
Approximately 175000
cancer cases are diagnosed annually in children younger than age 15 years worldwide, 1 with an annual increase
of around 0.9 % in incidence
rate in the developed world, only partly explained by improved
diagnosis and reporting.1, 2 Childhood
cancer is rare and its survival
rate has increased significantly over the years owing to advancement in treatment technologies; however, it is still a leading cause
of death among children and adolescents in developed countries, ranking second among children aged 1 to 14 years in the United States, surpassed only by accidents.1, 3 Childhood
cancer is also emerging as a major cause
of death in the last few years in Asia, Central and South America, Northwest Africa, and the Middle East, where death
rates from preventable communicable diseases are declining.2
Rates of New Deadly Skin
Cancers Double Over Last 3 Decades; Cases in Young Women Account for Majority
of Diagnoses (06/11/2015)
What was unknown, however, was the
rate that acute pancreatitis precedes a
diagnosis of pancreatic
cancer and the time between these two
diagnoses.
Co-author Professor Fabio Levi (MD), Head
of the
Cancer Epidemiology Unit at the Institute of Social and Preventive Medicine, Centre Hospitalier Universitaire Vaudois and University of Lausanne, (Switzerland), said: «Besides enforcing tobacco control — essentially by increasing taxation — national governments and EU policy makers must ensure that all EU citizens have access to the best screening, diagnosis and treatment, including those from central and eastern Europe where major delays are still observed and where cancer mortality rates tend to be higher as a result.&
Cancer Epidemiology Unit at the Institute
of Social and Preventive Medicine, Centre Hospitalier Universitaire Vaudois and University
of Lausanne, (Switzerland), said: «Besides enforcing tobacco control — essentially by increasing taxation — national governments and EU policy makers must ensure that all EU citizens have access to the best screening,
diagnosis and treatment, including those from central and eastern Europe where major delays are still observed and where
cancer mortality rates tend to be higher as a result.&
cancer mortality
rates tend to be higher as a result.»
«The increased death
rate is cause for concern, because the prognosis for this tumour is bleak, with less than five percent
of pancreatic
cancer patients surviving for five years after
diagnosis.
In 2011, the
rate of thyroid
cancer diagnosis was 15 times what it was in 1993, yet there was no change in thyroid
cancer mortality, Heyong Sik Ahn
of Korea University in Seoul and colleagues reported in The New England Journal
of Medicine in November 2014.
With samples taken from 242 people, 24
of whom had a
cancer diagnosis, the worms made the correct
diagnosis 96 per cent
of the time, a success
rate that the researchers say is better than any blood test.
But Li points out that women with more frequent visits would probably have more mammograms, which is associated with higher
rates of breast
cancer diagnosis.
Cancer of the pancreas, with a 5 % survival rate within five years of diagnosis, is the fourth leading cause of cancer related d
Cancer of the pancreas, with a 5 % survival
rate within five years
of diagnosis, is the fourth leading cause
of cancer related d
cancer related deaths.
Nevertheless, the survival
rate for lung
cancer is dismal: 80 percent
of patients die within five years
of diagnosis largely due to the disease's aggressive tendency to spread throughout the body.
Ibdah's research team used the databases Surveillance, Epidemiology and End Results (SEER) and the North American Association
of Central
Cancer Registries (NAACCR) to analyze the prevalence, stage and survival rates for colorectal cancer diagnoses in the U.S. based on race and ethnicity from 1973 to
Cancer Registries (NAACCR) to analyze the prevalence, stage and survival
rates for colorectal
cancer diagnoses in the U.S. based on race and ethnicity from 1973 to
cancer diagnoses in the U.S. based on race and ethnicity from 1973 to 2009.
The survival
rates are poor: around 15 out
of 100 women will survive advanced breast
cancer for 5 years or more after
diagnosis.
The analysis also found that the chance
of pregnancy was reduced in all age groups, with substantial variations between different
cancer diagnoses — notably, reduced pregnancy
rates in women with cervical
cancer, breast
cancer and leukemia.
«Ovarian
cancer is a very complicated disease and survival
rates are low, with only 46 %
of women living beyond five years after
diagnosis.
«When you have a
cancer that has a 80 to 90 percent mortality
rate within five years
of diagnosis, and you discover evidence that a small percentage
of people may have actionable mutations, that means that you could reduce mortality,» said Bueno.
The
rate of skin
cancer diagnosis is rising in minority populations; among Hispanics it has increased by 22 % since 1992, according to one estimate.
The cardiovascular death
rate, meanwhile, was more than twice as high among the men in the first month after
diagnosis than it was among
cancer - free men, although it was just 9 % higher over the course
of the whole year.
By 2014, researchers had identified about 700 patients with the
cancer who had a 20 - year survival
rate of 69 percent due to early
diagnoses and aggressive surgery.
Prevention and early detection improve survival
rates and treatment options, but — beyond the stage
of the
cancer at
diagnosis — the type
of the breast
cancer dictates what one's treatment options are.
In the Swedish study, the effects
of supplemental and dietary vitamin C were observed on breast
cancer survival
rate following breast
cancer diagnosis in a total
of 17,696 women.
The report also finds that compared to non-Hispanic whites, Hispanic / Latino Americans have a later stage
of diagnosis for many
cancers, including breast and melanoma and have generally similar 5 - year survival, except for melanoma, for which survival
rates are lower in Hispanic compared to non-Hispanic white men (79 % versus 87 %) and women (88 % versus 92 %).
Menzies says a number
of factors may be behind the higher death
rates, including later
diagnosis, reduced uptake
of or access to treatment, greater comorbidities, and higher
rates of more aggressive
cancers.
The
rates of late
diagnosis of cancer are set to increase dramatically as further barriers to primary health care are increased through co-payments.
As a consequence, late
diagnosis of cancer is far more common among Aboriginal and Torres Strait Islander than other Australians, with this leading to poor
cancer outcomes, including higher
rates of mortality.
The gap in survival
rates can be explained by factors such as advanced
cancer at
diagnosis, reduced access to and uptake
of treatment, higher
rates of comorbidities, and language barriers.